Prosensa To Participate At Upcoming Investor Conferences

Leiden, The Netherlands, Jan. 31, 2014 (GLOBE NEWSWIRE) -- Prosensa Holding N.V. (NASDAQ: RNA) announced today that it is schedule to participate at the following investor conferences in  February.
  • 16 th Annual BIO CEO & Investor Conference, Monday, February 10, 2014
  • Corporate Presentation: 9:30 a.m. Eastern Time (webcast available)
  • Panel Participation: 2:00 p.m. Eastern Time (no webcast available)
  • Leerink Partners Global Healthcare Conference 2014,Thursday, February 13, 2014
  • Fireside Chat: 11:35 a.m. Eastern Time (webcast available)
  • Canaccord Genuity Orphan Drug One-on-One Day, Monday, February 24, 2014   
  • 2014 Citi Healthcare Conference, Tuesday, February 25, 2014
  • Panel Participation, 9:40 a.m. Eastern Time (no webcast available)

Live webcasts where available can be accessed through the Investors & Media section of the Prosensa corporate website at http://ir.prosensa.eu/events.cfm and will be archived for 90 days.

About Prosensa Holding N.V.

Prosensa (NASDAQ: RNA) is a Dutch biotechnology company engaged in the discovery and development of RNA-modulating therapeutics for the treatment of genetic disorders. Its primary focus is on rare neuromuscular and neurodegenerative disorders with a large unmet medical need, including Duchenne muscular dystrophy, myotonic dystrophy and Huntington's disease.  www.prosensa.com
CONTACT: Prosensa Holding N.V.         Celia Economides, Senior Director IR & Corporate Communications         Phone: +1 917 941 9059         Email: c.economides@prosensa.nl

Prosensa Holding B.V. Logo

If you liked this article you might like

Sarepta Updates Eteplirsen Study Results, FDA Filing Still on for Mid Year

Jim Cramer's 'Mad Money' Recap: Knowing Where to Look for Bargains

Prosensa Holding (RNA) Upgraded From Sell to Hold

The Nominees for Best Biotechnology Co. CEO of 2014 Are...

Biotech Stock Mailbag: Aethlon Medical, Oxigene, Sarepta